Walsh Kathleen E 4
4 · Beam Therapeutics Inc. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
Walsh Kathleen E
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+10,391→ 10,391 totalExercise: $55.58Exp: 2032-09-01→ Common Stock (10,391 underlying)
Footnotes (1)
- [F1]The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.